Loading chat...

US SB4066

Bill

Status

Introduced

3/11/2026

Primary Sponsor

Josh Hawley

Click for details

Origin

Senate

119th Congress

AI Summary

Legislative Description

A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

3/11/2026

Committee Referrals

Health, Education, Labor, And Pensions3/11/2026

Full Bill Text

No bill text available